Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Gene Rank Value Type Network Comparison Type description Interaction Map red green Filtered network_comparison
Results: HTML CSV LaTeX Showing element 2700 to 2749 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2700\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
short coiled-coil protein; short coiled coil protein. [source:refseq;acc:nm\_032547]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5239.33\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5260\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00395\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2701\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dynein light chain 2. [source:refseq;acc:nm\_080677]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2702\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
creatine kinase, sarcomeric mitochondrial precursor (ec 2.7.3.2) (s- mtck) (mib-ck) (basic-type mitochondrial creatine kinase). [source:swissprot;acc:p17540]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8971.66\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9006.92\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00393\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2703\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
creatine kinase, ubiquitous mitochondrial precursor (ec 2.7.3.2) (u- mtck) (mia-ck) (acidic-type mitochondrial creatine kinase). [source:swissprot;acc:p12532]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8972.87\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9007.71\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00388\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2704\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
creatine kinase, m chain (ec 2.7.3.2) (m-ck). [source:swissprot;acc:p06732]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8980.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9013.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0037\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2705\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein cgi-27 (c21orf19-like protein). [source:swissprot;acc:q9y316]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4137.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4152.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00365\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2706\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peptidyl prolyl isomerase h; cyclophilin h. [source:refseq;acc:nm\_006347]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
8979.61\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
9012.31\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00364\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2707\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
prp18 pre-mrna processing factor 18 homolog. [source:refseq;acc:nm\_003675]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2708\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
j domain protein c21orf55. [source:swissprot;acc:q9nx36]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8979.78\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9012.42\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00363\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2709\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
testis-specific protein tex28. [source:swissprot;acc:o15482]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5603.24\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5583.64\vspace{3pt}}}&\multirow{20}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00351\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2710\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
similar to nuclear protein e3-3 orf1. [source:sptrembl;acc:q9bu61]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2711\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
n-acetyllactosaminide beta-1,3-n-acetylglucosaminyltransferase (ec 2.4.1.149) (poly-n-acetyllactosamine extension enzyme) (i-beta- 1,3-n-acetylglucosaminyltransferase) (ignt) (udp-glcnac:betagal beta- 1,3-n-acetylglucosaminyltransferase 6). [source:swissprot;acc:o43505]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5332.98\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5351.72\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2712\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
a kindred of iglon. [source:refseq;acc:nm\_173808]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5603.24\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5583.64\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2713\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ankyrin-repeat family a protein 2 (rfxank-like 2). [source:swissprot;acc:q9h9e1]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2714\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
inflammation-related g protein-coupled receptor ex33. [source:refseq;acc:nm\_020370]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2715\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
huntingtin interacting protein e; huntingtin interactor protein e. [source:refseq;acc:nm\_007076]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5332.98\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5351.72\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2716\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial import inner membrane translocase subunit tim10. [source:swissprot;acc:q9y5j8]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2717\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
palmitoyl-protein thioesterase 1 precursor (ec 3.1.2.22) (palmitoyl- protein hydrolase 1). [source:swissprot;acc:p50897]\vspace{3pt}}&\multirow{9}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5603.24\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5583.64\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2718\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-soluble nsf attachment protein (snap-beta) (n-ethylmaleimide- sensitive factor attachment protein, beta). [source:swissprot;acc:q9h115]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2719\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
syntaxin 16 (syn16). [source:swissprot;acc:o14662]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2720\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
27 kda golgi snare protein (golgi snap receptor complex member 2) (membrin). [source:swissprot;acc:o14653]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2721\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
syntaxin 1a (neuron-specific antigen hpc-1). [source:swissprot;acc:q16623]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2722\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
alpha-soluble nsf attachment protein (snap-alpha) (n-ethylmaleimide- sensitive factor attachment protein, alpha). [source:swissprot;acc:p54920]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2723\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adipocyte plasma membrane-associated protein (bscv protein). [source:swissprot;acc:q9hdc9]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2724\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
synaptosomal-associated protein 29 (snap-29) (vesicle-membrane fusion protein snap-29) (soluble 29 kda nsf attachment protein). [source:swissprot;acc:o95721]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2725\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
syntaxin 1b. [source:swissprot;acc:q15531]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2726\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fumarate hydratase, mitochondrial precursor (ec 4.2.1.2) (fumarase). [source:swissprot;acc:p07954]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5332.98\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5351.72\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2727\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma antigen p15 (melanoma-associated antigen recognized by t lymphocytes). [source:swissprot;acc:q13084]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5603.24\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5583.64\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2728\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-binding protein rfxank (regulatory factor x subunit b) (rfx-b) (ankyrin repeat family a protein 1). [source:swissprot;acc:o14593]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2729\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
probable serine/threonine-protein kinase kiaa0537 (ec 2.7.1.-). [source:swissprot;acc:o60285]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5333\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5351.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00349\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2730\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
myelin gene expression factor 2. [source:refseq;acc:nm\_016132]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5214.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5197.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00341\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2731\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor p65 (nuclear factor nf-kappa-b p65 subunit). [source:swissprot;acc:q04206]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
7913.63\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7939.94\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00332\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2732\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor relb (i-rel). [source:swissprot;acc:q01201]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2733\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nf-kappab inhibitor alpha (major histocompatibility complex enhancer- binding protein mad3) (i-kappa-b-alpha) (ikappabalpha) (ikb-alpha). [source:swissprot;acc:p25963]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2734\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
coproporphyrinogen iii oxidase, mitochondrial precursor (ec 1.3.3.3) (coproporphyrinogenase) (coprogen oxidase) (cox). [source:swissprot;acc:p36551]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2735\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
creatine kinase, b chain (ec 2.7.3.2) (b-ck). [source:swissprot;acc:p12277]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8991.87\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9019.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00313\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2736\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
inhibitor of growth family, member 1; inhibitor of growth 1. [source:refseq;acc:nm\_005537]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4887.59\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4902.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00296\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2737\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tfiih basal transcription factor complex p44 subunit (basic transcription factor 2 44 kda subunit) (btf2-p44) (general transcription factor iih polypeptide 2). [source:swissprot;acc:q13888]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4486.83\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4499.52\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00283\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2738\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tfiih basal transcription factor complex p62 subunit (basic transcription factor 62 kda subunit) (btf2-p62) (general transcription factor iih polypeptide 1). [source:swissprot;acc:p32780]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2739\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
inhibitor of growth family, member 1-like; inhibitor of growth 1-like. [source:refseq;acc:nm\_001564]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4877.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4890.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00264\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2740\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-directed rna polymerases i, ii, and iii 17.1 kda polypeptide (ec 2.7.7.6) (rpb17) (rpb8) (rpabc3). [source:swissprot;acc:p52434]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4200.59\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4210.94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00246\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2741\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sorting nexin 5. [source:swissprot;acc:q9y5x3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5339.67\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5327.2\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00234\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2742\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
oligopeptide transporter, small intestine isoform (peptide transporter 1) (intestinal h+/peptide cotransporter) (solute carrier family 15, member 1). [source:swissprot;acc:p46059]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10198.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10174.3\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2743\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s acidic ribosomal protein p2. [source:swissprot;acc:p05387]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4824.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4813.92\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0022\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2744\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
oligopeptide transporter, kidney isoform (peptide transporter 2) (kidney h+/peptide cotransporter) (solute carrier family 15, member 2). [source:swissprot;acc:q16348]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10143.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10163.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00197\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2745\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tripartite motif protein 3 (ring finger protein 22) (brain-expressed ring finger protein). [source:swissprot;acc:o75382]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7746.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7757.23\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00137\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2746\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hpaii tiny  fragments locus 9c. [source:refseq;acc:nm\_022727]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4188.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4194.22\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2747\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
putatative 28 kda protein. [source:refseq;acc:nm\_020143]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4708.68\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4702.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0013\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2748\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
syntaxin 6. [source:swissprot;acc:o43752]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5296.39\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5301.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00089\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2749\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
alpha-fetoprotein enhancer binding protein (at motif-binding factor) (at-binding transcription factor 1). [source:swissprot;acc:q15911]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7776.91\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7783.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00084\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/